Similar to GLP-1(7-37), exenatide also acts as an agonist for GLP-1(7-37), but shows resistance to DPP-4 degradation and has a lower renal clearance rate in human, making exenatide the first successfully developed GLP-1 drug [6]
Each ingredient is carefully selected for its potential role in promoting satiety, supporting glucose metabolism, and helping individuals maintain consistent health habits
No bacterial growth concerns
For now, Lilly has emerged as the unrivaled champion of GLP-1.
Further, liraglutide protects against vascular oxidative stress via attenuating eNOS (endothelial NO synthase) s-glutathionylation (a hallmark of eNOS uncoupling) and increasing NO bioavailability [15]
Generative AI statement The authors declare that no Gen AI was used in the creation of this manuscript